Legend Biotech (LEGN) Change in Cash (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Change in Cash data on file, last reported at -$255.5 million in Q1 2026.

• Quarterly Change in Cash fell 264.84% year-over-year to -$255.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $204.6 million (up 144.85% YoY) and the FY2025 annual result came in at $615.2 million, up 162.08% from the prior year.
• Change in Cash retreated to -$255.5 million in Q1 2026, from $623.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $909.7 million in Q2 2023 to a low of -$696.3 million in Q2 2024.
• A 5-year average of -$2.4 million and a median of -$25.6 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash slumped 611.55% — and 2023, when it surged 31773.09%.
• Tracing LEGN's Change in Cash over 5 years: stood at -$25.6 million in 2022, then jumped by 1322.17% to $312.8 million in 2023, then slumped by 155.18% to -$172.6 million in 2024, then soared by 460.95% to $623.0 million in 2025, then plunged by 141.01% to -$255.5 million in 2026.
• The last three Change in Cash figures came in at -$255.5 million (Q1 2026), $623.0 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.